What to know
More than 140 scientific papers have been published using data from the National ART Surveillance System (NASS). This web page provides a list of recent publications using NASS data, including annual surveillance reports.
2024
Braun CB, DeSantis CE, Lee JC, Kissin DM, Kawwass JF. Trends and outcomes of fresh and frozen donor oocyte cycles in the United States. Fertil Steril. 2024;122(5):844–855.
Winter AS, Yartel AK, Fountain C, Cheslack-Postava K, Zhang Y, Schieve LA, Kissin DM, Bearman P. The role of multiple birth and birth complications in the association between assisted reproductive technology conception and autism diagnosis. Am J Epidemiol. 2024;193(10):1426-1432.
Adashi EY, Penzias AS, Gruppuso PA, Kulkarni AD, Zhang Y, Kissin DM, Gutman R. Iatrogenic and demographic determinants of the national plural birth increase. Fertil Steril. 2024;121(5):756–764.
Zhang Y, Kissin DM, Liao KJ, DeSantis CE, Yartel AK, Gutman R. Multiple imputation of missing race/ethnicity information in the National Assisted Reproductive Technology Surveillance System. J Womens Health (Larchmt). 2024;33(3):328–338.
Korkidakis A, DeSantis C, Kissin D, Hacker M, Koniares K, Yartel A, Adashi E, Penzias A. State insurance mandates and racial and ethnic inequities in assisted reproductive technology utilization. Fertil Steril. 2024;121(1):54–62.
2023
Centers for Disease Control and Prevention. 2021 Assisted Reproductive Technology Fertility Clinic and National Summary Report. U.S. Dept of Health and Human Services; 2023.
Sunderam S, Zhang Y, Jewett A, Mardovich S, Kissin DM. State-Specific Assisted Reproductive Technology Surveillance, United States: 2021 Data Brief. Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2023.
Gaskins AJ, Zhang Y, Chang J, Kissin DM. Predicted probabilities of live birth following assisted reproductive technology using United States national surveillance data from 2016–2018.Am J Obstet Gynecol. 2023;228(5):557.e1–557.e10.
Weiss MS, Luo C, Zhang Y, Chen Y, Kissin DM, Satten GA, Barnhart KT. Fresh vs. frozen embryo transfer: new approach to minimize the limitations of using national surveillance data for clinical research. Fertil Steril. 2023;119(2):186–94.
Lee J, DeSantis C, Boulet S, Kawwass J. Embryo donation: national trends and outcomes, 2004–2019. Am J Obstet Gynecol. 2023;228(3):318.e1–318.e7.
Lee J, DeSantis C, Yartel A Kissin D, Kawwass J. Association of state insurance coverage mandates with assisted reproductive technology care discontinuation. Am J Obstet Gynecol. 2023;228(3):315.e1–315.e14.
2022
Centers for Disease Control and Prevention. 2020 Assisted Reproductive Technology Fertility Clinic and National Summary Report. U.S. Dept of Health and Human Services; 2022.
Sunderam S, Zhang Y, Jewett A, Mardovich S, Kissin DM. State-Specific Assisted Reproductive Technology Surveillance, United States: 2020 Data Brief. Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2022.
Roshong A, DeSantis C, Yartel A, Heitmann R, Kissin D, Pier B. Factors associated with large for gestational age infants born after frozen embryo transfer cycles. F S Rep. 2022;3(4):332–341.
Jewett A, Warner L, Kawwass J, Mehta A, Eisenberg M, Nangia A, Dupree J, Honig S, Hotaling J, Kissin D. Assisted reproductive technology (ART) cycles involving male factor infertility in the United States, 2017–2018: data from the National ART Surveillance System (NASS). F S Rep. 2022;3(2):124–130.
Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, Kroelinger CD, Barfield WD. Assisted reproductive technology surveillance – United States, 2018. MMWR Surveill Summ. 2022;71(suppl 4):1–19.
2021
Centers for Disease Control and Prevention. 2019 Assisted Reproductive Technology Fertility Clinic and National Summary Report. U.S. Dept of Health and Human Services; 2021.
Sunderam, S., Zhang, Y., Jewett, A., Kissin, D. State-Specific Assisted Reproductive Technology Surveillance, United States: 2019 Data Brief. Centers for Disease Control and Prevention; U.S. Dept of Health and Human Services; 2021.
Centers for Disease Control and Prevention. 2018 Assisted Reproductive Technology National Summary Report. U.S. Dept of Health and Human Services; 2021.
Chang J, Zhang Y, Boulet SL, Crawford SB, Copeland GE, Bernson D, Kirby RS, Kissin DM, Barfield WD, for States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Assisted reproductive technology and perinatal mortality: selected states (2006–2011). Am J Perinatol. Published online July 19, 2021. doi:10.1055/s-0041-1732451
2020
Centers for Disease Control and Prevention. 2018 Assisted Reproductive Technology Fertility Clinic Success Rates Report. U.S. Dept of Health and Human Services; 2020.
Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, Kroelinger CD, Barfield WD. Assisted reproductive technology surveillance – United States, 2017. MMWR Surveill Summ. 2020;69(suppl 9):1–20.
Schirmer DA 3rd, Kulkarni AD, Zhang Y, Kawwass JF, Boulet SL, Kissin DM. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy. Fertil Steril. 2020; 114(3):567–578.
Sites CK, Wilson D, Bernson D, Boulet S, Zhang Y. Number of embryos transferred and diagnosis of preeclampsia. Reprod Biol Endocrinol. 2020;18(1):68.
Sunderam S, Boulet SL, Kawwass JF, Kissin DM. Comparing fertilization rates from intracytoplasmic sperm injection to conventional in vitro fertilization among women of advanced age with non-male factor infertility: a meta-analysis. Fertil Steril. 2020; 113(2):354–363.